A detailed history of Deutsche Bank Ag\ transactions in Liquidia Corp stock. As of the latest transaction made, Deutsche Bank Ag\ holds 33,285 shares of LQDA stock, worth $380,114. This represents 0.0% of its overall portfolio holdings.

Number of Shares
33,285
Previous 25,083 32.7%
Holding current value
$380,114
Previous $300,000 10.67%
% of portfolio
0.0%
Previous 0.0%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$8.9 - $14.11 $72,997 - $115,730
8,202 Added 32.7%
33,285 $332,000
Q2 2024

Aug 14, 2024

BUY
$11.96 - $15.71 $29,397 - $38,615
2,458 Added 10.86%
25,083 $300,000
Q1 2024

May 15, 2024

BUY
$11.35 - $16.73 $13,892 - $20,477
1,224 Added 5.72%
22,625 $333,000
Q4 2023

Feb 14, 2024

SELL
$5.77 - $12.19 $4,223 - $8,923
-732 Reduced 3.31%
21,401 $257,000
Q3 2023

Nov 09, 2023

SELL
$6.27 - $8.15 $1.27 Million - $1.65 Million
-202,883 Reduced 90.16%
22,133 $140,000
Q2 2023

Aug 14, 2023

SELL
$6.63 - $9.9 $80,859 - $120,740
-12,196 Reduced 5.14%
225,016 $1.77 Million
Q1 2023

May 15, 2023

BUY
$5.72 - $7.91 $53,544 - $74,045
9,361 Added 4.11%
237,212 $1.64 Million
Q4 2022

Feb 13, 2023

BUY
$4.68 - $6.54 $1,488 - $2,079
318 Added 0.14%
227,851 $1.45 Million
Q3 2022

Nov 14, 2022

SELL
$3.73 - $8.39 $11,902 - $26,772
-3,191 Reduced 1.38%
227,533 $1.24 Million
Q2 2022

Aug 11, 2022

BUY
$3.37 - $7.55 $777,539 - $1.74 Million
230,724 New
230,724 $1.01 Million
Q3 2021

Nov 04, 2021

SELL
$2.28 - $2.95 $316,584 - $409,616
-138,853 Closed
0 $0
Q2 2021

Aug 11, 2021

BUY
$2.51 - $3.11 $302,332 - $374,602
120,451 Added 654.55%
138,853 $397,000
Q1 2021

May 13, 2021

SELL
$2.42 - $3.6 $3,993 - $5,940
-1,650 Reduced 8.23%
18,402 $49,000
Q4 2020

Feb 16, 2021

BUY
$2.6 - $5.79 $14,211 - $31,648
5,466 Added 37.47%
20,052 $59,000
Q3 2020

Nov 12, 2020

BUY
$4.34 - $8.28 $18,271 - $34,858
4,210 Added 40.57%
14,586 $72,000
Q2 2020

Aug 13, 2020

BUY
$4.86 - $11.44 $28,868 - $67,953
5,940 Added 133.9%
10,376 $87,000
Q1 2020

May 14, 2020

SELL
$3.31 - $7.15 $9,608 - $20,756
-2,903 Reduced 39.56%
4,436 $21,000
Q4 2019

Feb 14, 2020

SELL
$3.07 - $5.11 $23,565 - $39,224
-7,676 Reduced 51.12%
7,339 $31,000
Q3 2019

Nov 14, 2019

BUY
$3.29 - $8.24 $15,449 - $38,695
4,696 Added 45.51%
15,015 $52,000
Q2 2019

Aug 14, 2019

BUY
$7.92 - $11.39 $10,335 - $14,863
1,305 Added 14.48%
10,319 $81,000
Q1 2019

May 15, 2019

BUY
$10.82 - $21.79 $28,651 - $57,699
2,648 Added 41.6%
9,014 $102,000
Q4 2018

Feb 14, 2019

SELL
$16.38 - $37.18 $76,789 - $174,299
-4,688 Reduced 42.41%
6,366 $137,000
Q3 2018

Dec 21, 2021

BUY
$10.96 - $28.9 $14,116 - $37,223
1,288 Added 13.19%
11,054 $303,000
Q3 2018

Nov 14, 2018

BUY
$10.96 - $28.9 $107,035 - $282,237
9,766 New
9,766 $266,000

Others Institutions Holding LQDA

About Liquidia Corp


  • Ticker LQDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 64,362,300
  • Market Cap $735M
  • Description
  • Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil inje...
More about LQDA
Track This Portfolio

Track Deutsche Bank Ag\ Portfolio

Follow Deutsche Bank Ag\ and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.